Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Assessment of Metabolic dysfunction-associated steatotic liver disease, Alcohol-associated liver disease, and Metabolic dysfunction and alcohol-associated steatotic liver disease in open Mexican population
Jorge Emilio Lira-Vera; Ángel Daniel-Santana Vargas; Gabriela Gutiérrez-Reyes; Oscar Morales-Gutiérrez; María de Fátima Higuera-de la Tijera; Diana Montemira-Orozco; Christian Hinojosa-Segura; Moisés Martínez-Castillo; Samantha Sánchez-Valle; María de los Ángeles Lemus-Peña; Daniel Montes de Oca-Ángeles; Abigail Hernández-Barragán; Marisela Hernández-Santillán; Y.L. Béjar-Ramírez; José Luis Pérez-Hernández;
10.1016/j.aohep.2025.102149
P 56- SHORT-TERM RESPONSE OF P300 EVOKED POTENTIAL IN PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY TREATED WITH L-ORNITHINE, L-ASPARTATE
José Luis Pérez-Hernández; Christian Hinojosa-Segura; Diana Montemira-Orozco; Andrés Burak-Leipuner; Juana Zavala-Ramírez; Imram Cruz-Reyes; María Escobedo-Silva; Fátima Higuera-de la Tijera; Daniel Santana-Vargas;
Ann Hepatol. 2023;28 Supl 1:
O-33 PREVALENCE OF HIGH-RISK NON-ALCOHOLIC STEATOHEPATITIS ACCORDING TO THE FAST® INDEX IN A GROUP OF DIABETIC PATIENTS
Andrés Burak-Leipuner; Fatima Higuera-de la Tijera; Alfredo Servín-Caamaño; Javier Romero-Bermúdez; Laura Ceceña-Martínez; Felix García-Gorrosquieta; Kevin Vázquez-Hernández; Nidia Uribe-Rivera; Pablo Alagón-Fernández del Campo; Farid Vargas-Duran; Christian Hinojosa-Segura; Diana Montemira-Orozco; José Luis Pérez-Hernández;
Ann Hepatol. 2023;28 Supl 1: